Cargando…
The feasibility and value of assessing patient‐reported outcomes in pulmonary arterial hypertension
Pulmonary arterial hypertension (PAH) is a progressive pulmonary vascular disease that negatively impacts health‐related quality of life (HRQOL). The PAH‐symptoms and impact (PAH‐SYMPACT) questionnaire is a validated disease‐specific patient‐reported outcome (PRO) instrument that assesses a patient&...
Autores principales: | DuBrock, Hilary M., Reddy, Yogesh N., Durst, Louise A., Schroeder, Darrell R., Park, Grace, Cajigas, Hector R., Kane, Garvan C., Kushwaha, Sudhir S., McCully, Robert B., Murphy, Joseph G., Anand, Vidhu, Krowka, Michael J., Frantz, Robert P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575699/ https://www.ncbi.nlm.nih.gov/pubmed/36262468 http://dx.doi.org/10.1002/pul2.12143 |
Ejemplares similares
-
Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension: Initial Single-Center Experience
por: Anand, Vidhu, et al.
Publicado: (2019) -
Bubble Trouble in COVID-19
por: DuBrock, Hilary M., et al.
Publicado: (2020) -
Bezold–Jarisch reflex mediated syncope in pulmonary arterial hypertension: An illustrative case series
por: Agboola, Kolade M., et al.
Publicado: (2022) -
Temporal Trends in Portopulmonary Hypertension Model for End-stage Liver Disease Exceptions and Outcomes
por: del Valle, Kathryn T., et al.
Publicado: (2022) -
Impact of age on pulmonary artery systolic pressures at rest and with exercise
por: Kane, Garvan C, et al.
Publicado: (2016)